ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Kissei Pharmaceutical Co., Ltd. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 63 studies whose lead sponsor is Kissei Pharmaceutical Co., Ltd. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 10, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Kissei Pharmaceutical with Jiangsu HengRui Medicine and Hoffmann-La Roche →

Pipeline: 4 programs

Each counted once: 4 with a study Kissei Pharmaceutical Co., Ltd. leads registered in the last two years.

  • Phase 2
  • Phase 3

The 2 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Kissei Pharmaceutical Co., Ltd.’s own registered studies; Kissei Pharmaceutical Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Kissei Pharmaceutical Co., Ltd.’s studies test, most open studies first — 14 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 4 more

Coming up

2 of Kissei Pharmaceutical Co., Ltd.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. 1N

Add all 2 to your calendar (.ics) → With an account.

All 63 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now35%
  • Under way, not recruiting23%
  • Completed5486%
  • Stopped early46%Terminated 3 · Withdrawn 1

Phase

  • Phase 230
  • Phase 328
  • Phase 14
  • Phase 41

Where

  • Japan57
  • United States4
  • Bulgaria2
  • Czechia2
  • France2
  • Poland2

Over the years

  1. 12
  2. 13
  3. 14
  4. 15
  5. 16
  6. 17
  7. 18
  8. 519
  9. 20
  10. 21
  11. 22
  12. 23
  13. 24
  14. 25
  15. 126

By the year each study started; 1 started before 2012. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Kissei Pharmaceutical Co., Ltd.

  • Kissei Pharmaceutical Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    63 studies

Studies

Recruiting first, then most recently updated. Showing 50 of 63. Browse all 63 →